Incidence and Predictors of Opportunistic Infections Among Adult HIV Infected Patients on Anti-Retroviral Therapy at Dessie Comprehensive Specialized Hospital, Ethiopia: A Retrospective Follow-Up Study

References

• Gona P, Van Dyke RB, Williams PL, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. JAMA. 2006;296(3):292–300. doi:10.1001/jama.296.3.292
   PubMed Web of Science ®Google Scholar
• Iroezindu M, Ofondu E, Hausler H, Van Wyk B. Prevalence and risk factors for opportunistic infections in HIV patients receiving antiretroviral therapy in a resource-limited setting in Nigeria. J AIDs Clin Res. 2013;3:2.
   Google Scholar
• Podlekareva D, Mocroft A, Dragsted UB, et al. Factors associated with the development of opportunistic infections in HIV-1–infected adults with high CD4+ cell counts: a EuroSIDA study. J Infect Dis. 2006;194(5):633–641.
   PubMed Web of Science ®Google Scholar
• WHO. Global health sector strategy on HIV. 2016–2021; 2019. Available from: https://wwwwhoint/news-room/fact-sheets/detail/hiv-aids. Accessed March 29, 2022.
   Google Scholar
• Kharsany AB, Karim QA. HIV infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10:34.
   PubMedGoogle Scholar
• Low A, Gavriilidis G, Larke N, et al. Incidence of opportunistic infections and the impact of antiretroviral therapy among HIV-infected adults in low-and middle-income countries: a systematic review and meta-analysis. Clin Infect Dis. 2016;62(12):1595–1603.
   PubMed Web of Science ®Google Scholar
• Ethiopian Public Health Institute and ICAP at Columbia University. Ethiopia Population-Based HIV Impact Assessment (EPHIA). Summary Sheet: Preliminary Findings; 2017–2018. 2018:4–7.
   Google Scholar
• IeDEA T. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-and high-income countries. J Acquired Immune Deficiency Syndromes. 2014;65(1):e8.
   PubMed Web of Science ®Google Scholar
• Control CfD, Prevention. Guidelines for the Prevention and Treatment of opportunistic Infections in HIV-infected Adults and Adolescents. MMWR. 2009;58(4):1–206.
   PubMedGoogle Scholar
• Edwards LA. Establishing a Pastoral Care Ministry for Those Infected and Affected by HIV/AIDS at the Robert Pinn Memorial Baptist Church. Eastern University; 2015.
   Google Scholar
• Seyler C, Messou E, Gabillard D, Inwoley A, Alioum A, Anglaret X. Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis. AIDS Res Hum Retroviruses. 2007;23(11):1338–1347.
   PubMed Web of Science ®Google Scholar
• Zhou J, Paton N, Ditangco R. AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational Database. Int J STD AIDS. 2007;18(7):446–452.
   PubMed Web of Science ®Google Scholar
• Arefaine ZG, Abebe S, Bekele E, Adem A, Adama Y. Incidence and predictors of HIV related opportunistic infections after initiation of highly active antiretroviral therapy at Ayder Referral Hospital, Mekelle, Ethiopia: a retrospective single centered cohort study. PLoS One. 2020;15(4):e0229757.
   PubMed Web of Science ®Google Scholar
• Moges N, Kassa G. Prevalence of opportunistic infections and associated factors among HIV positive patients taking anti-retroviral therapy in DebreMarkos Referral Hospital, Northwest Ethiopia. J AIDs Clin Res. 2014;5(5):1–300.
   Google Scholar
• World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children. World Health Organization; 2007.
   Google Scholar
• Mariam ZT, Abebe G, Mulu A. Opportunistic and other intestinal parasitic infections in AIDS patients, HIV seropositive healthy carriers and HIV seronegative individuals in southwest Ethiopia. East Afr J Public Health. 2008;5(3):169–173.
   PubMedGoogle Scholar
• Nsagha DS, Njunda AL, Assob NJC, Ayima CW, Tanue EA, Kwenti TE. Intestinal parasitic infections in relation to CD4+ T cell counts and diarrhea in HIV/AIDS patients with or without antiretroviral therapy in Cameroon. BMC Infect Dis. 2015;16(1):1–10.
   Web of Science ®Google Scholar
• Patel SD, Javadekar TB, Kinariwala D. Enteric opportunistic parasitic infections in HIV seropositive patients at tertiary care teaching hospital. Natl J Med Res. 2015;5(3):190–194.
   Google Scholar
• Shenoy N, Ramapuram JT, Shenoy A, Ahmed J, Srikant N. Incidence of opportunistic infections among HIV-positive adults on highly active antiretroviral therapy in a teaching hospital, India: prospective study. J Int Assoc Providers AIDS Care. 2017;16(3):309–311.
   PubMedGoogle Scholar
• Sun H, Chen M, Hsieh S, et al. Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy. Jpn J Infect Dis. 2006;59(5):311.
   PubMed Web of Science ®Google Scholar
• Shearer K, Maskew M, Ajayi T, et al. Incidence and predictors of herpes zoster among antiretroviral therapy-naive patients initiating HIV treatment in Johannesburg, South Africa. Int J Infect Dis. 2014;23:56–62.
   PubMed Web of Science ®Google Scholar
• Ghate M, Deshpande S, Tripathy S, et al. Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. Int j Infect Dis. 2009;13(1):e1–e8.
   PubMedGoogle Scholar
• De Beaudrap P, Etard J-F, Diouf A, et al. Incidence and determinants of new AIDS-defining illnesses after HAART initiation in a Senegalese cohort. BMC Infect Dis. 2010;10(1):1–9.
   PubMed Web of Science ®Google Scholar
• Candiani T, Pinto J, Cardoso CAA, et al. Impact of highly active antiretroviral therapy (HAART) on the incidence of opportunistic infections, hospitalizations and mortality among children and adolescents living with HIV/AIDS in Belo Horizonte, Minas Gerais State, Brazil. Cadernos de Saúde Pública. 2007;23:S414–S23.
   PubMed Web of Science ®Google Scholar
• Buchacz K, Lau B, Jing Y, et al. Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000–2010. J Infect Dis. 2016;214(6):862–872.
   PubMed Web of Science ®Google Scholar
• Sabasaba A, Mwambi H, Somi G, Ramadhani A, Mahande MJ. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study. BMC Infect Dis. 2019;19(1):1–8.
   PubMed Web of Science ®Google Scholar
• Dalbo M, Tamiso A. Incidence and predictors of tuberculosis among HIV/AIDS infected patients: a five-year retrospective follow-up study. Adv Infect Dis. 2016;6(02):70.
   Google Scholar
• Wachamo D, Bonja F. Magnitude of Opportunistic Infections and Associated Factors Among HIV-Positive Adults on ART at Selected Public Hospitals in Sidama National Regional State, Southern Ethiopia. HIV/AIDS. 2020;12:479.
   Google Scholar
• Mocroft A, Youle M, Phillips AN, et al. The incidence of AIDS-defining illnesses in 4883 patients with human immunodeficiency virus infection. Arch Intern Med. 1998;158(5):491–497.
   PubMedGoogle Scholar
• Damtie D, Yismaw G, Woldeyohannes D, Anagaw B. Common opportunistic infections and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia. BMC Res Notes. 2013;6(1):1–7.
   PubMedGoogle Scholar
• Tewachew AS, Mekonnen WN, Mekuria AD, Amare YE. Determinants of Opportunistic Infections Among HIV-Positive Patients on HAART in Debre Berhan Referral Hospital, North Shoa Zone, Ethiopia, 2020: a Case–Control Study. HIV/AIDS. 2021;13:337.
   Google Scholar
• Alene KA, Nega A, Taye BW. Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infect Dis. 2013;13(1):1–9.
   PubMedGoogle Scholar
• Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. Aids. 2005;19(18):2109–2116.
   PubMed Web of Science ®Google Scholar
• Melkamu H, Seyoum B, Dessie Y. Determinants of tuberculosis infection among adult HIV positives attending clinical care in western Ethiopia: a case-control study. AIDS Res Treat. 2013;2013:64.
   Google Scholar
• Diaz A, Del Romero J, Rodriguez C, et al. Effects of region of birth, educational level and age on late presentation among men who have sex with men newly diagnosed with HIV in a network of STI/HIV counselling and testing clinics in Spain. Eurosurveillance. 2015;20(14):21088.
   Web of Science ®Google Scholar
• Sobrino-Vegas P, Miguel LG-S, Caro-Murillo AM, et al. Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res. 2009;7(2):224–230.
   PubMed Web of Science ®Google Scholar
• Ford N, Vitoria M, Hirnschall G, Doherty M. Getting to zero HIV deaths: progress, challenges and ways forward. J Int AIDS Soc. 2013;16(1):54.
   Web of Science ®Google Scholar
• Temesgen B, Kibret GD, Alamirew NM, et al. Incidence and predictors of tuberculosis among HIV-positive adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: a retrospective record review. BMC Public Health. 2019;19(1):1–9.
   PubMed Web of Science ®Google Scholar